Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
McKesson
Dow
Merck
Julphar
Colorcon
Citi
Mallinckrodt

Generated: February 17, 2019

DrugPatentWatch Database Preview

Alvogen Malta Company Profile

« Back to Dashboard

What is the competitive landscape for ALVOGEN MALTA, and what generic and branded alternatives to ALVOGEN MALTA drugs are available?

ALVOGEN MALTA has twenty-four approved drugs.



Summary for Alvogen Malta
US Patents:0
Tradenames:25
Ingredients:22
NDAs:24
Patent Litigation for Alvogen Malta: See patent lawsuits for Alvogen Malta

Drugs and US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta NATEGLINIDE nateglinide TABLET;ORAL 205055-001 Dec 11, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Alvogen Malta DISULFIRAM disulfiram TABLET;ORAL 091681-001 Aug 8, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Alvogen Malta ZESTRIL lisinopril TABLET;ORAL 019777-003 May 19, 1988 AB RX Yes No ➤ Sign Up ➤ Sign Up
Alvogen Malta RIVASTIGMINE rivastigmine FILM, EXTENDED RELEASE;TRANSDERMAL 204403-001 Sep 3, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Alvogen Malta SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 090910-001 Nov 18, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 3,839,574 ➤ Sign Up
Alvogen Malta ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-002 Jul 20, 1989 4,374,829*PED ➤ Sign Up
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 3,663,607 ➤ Sign Up
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 3,836,671 ➤ Sign Up
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 3,663,607 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
QuintilesIMS
Fish and Richardson
Daiichi Sankyo
Harvard Business School
Express Scripts
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.